维普中文期刊产品整合服务
61篇 您的检索式:作者名="Moran EM"
    题名 作者 年代 出处 被引量
1Angioimmunoblastic lymphadenopathy with dysproteinaemia显示文摘 Moran EM Rappaport B 1974Lancet1974,1,:1
2Epidemiological and clinical aspects of nonsteroidal anti -inflammatory drugs and cancer risks显示文摘Moran EM 2002J Environ Pathol ToxiCO Oncol2002,21,2:1
3Angio-immunoblastic Lymphadenopathy with dysproteinaemia显示文摘Frizzera G Moran EM Rappaport H 1974Lancet1974,1,7866:1
4Angioimmunoblastic lymphadenopathy with dysproteinaemia显示文摘Frizzera G Moran EM Rappaort B 1974Lancet1974,7866,:1
5Angioimmunoblastic lymphadenopathy with dysproteinemia显示文摘Frizzera G Moran EM Rappaport H 1974Lancet1974,1,:1
6Epidemiological and clinical aspects of nonsteroidalantiinflammatory drugs and cancer risks显示文摘Moran EM 2002J Environ PatholToxicol Oncol2002,21,2:1
7Reepithelialized orthotopic tracheal allografts expand memory cytotoxic T lymphocytes but show no evidence of chronic rejection 显示文摘Cleven HA Genden EM Moran TM 2005Transplantation2005,79,:1
8Angio-immunoblastic Lymphadenopathy with dysproteinaemia 显示文摘Frizzera G Moran EM Rappaport H 1974Lancet1974,1,7866:1
9Interleukin-17A induction of angiogenesis,cell migration,and cytoskeletal rearrangement显示文摘Moran EM Connolly M Gao W 2011Arthritis Rheum2011,63,11:1
10Reepithelialized orthotopic tracheal allografts expand memory cytotoxic T lymphocytes but show no evidence of chronic rejection显示文摘Cleven HA Genden EM Moran TM 0,,:1
11Human rheumatoid arthritis tissue production of IL-17A drives matrix and cartilage degradation: synergy with tumournecrosis factor-alpha, 0ncostatin M and response to bio- logic therapies 显示文摘Moran EM Mullan R McCormick J 2009Arthritis Res Ther2009,11,4:1
12Interleukin-17A induction of angiogenesis, cell migration, and cytoskeletal rearrangement显示文摘Moran EM Connolly M Gao W 2011Arthritis Rheum2011,63,11:1
13Epidemiological and clinical aspects of nonsteroidal anti-inflammatory drugs and cancer risks显示文摘Moran EM 2002J Environ Pathol Toxicol Oncol2002,21,2:1
14Human rheumatoid arthritis tissue production of IL-17A drives matrix and cartilage degradation: synergy with tumour necrosis factor-alpha, Oneostatin M and response to biologic therapies 显示文摘Moran EM Mullan R McCormick J 2009Arthritis Res Ther2009,11,4:1
15Epidemiological and clinical aspects of nonsteroidal anti-inflammatory drugs and cancer risks显示文摘Moran EM 2002J Environ Pathol Toxicol Oncol2002,21,:1
16Epidemiological and clinical aspects of nonsteroidal anti-in-flammatory drugs and cancer risks显示文摘 2002J Environ Pathol Toxicol Oncol2002,21,2:1
17Early results of surgery in 123 patients with pseudomyxoma peritonei from a perforated appendiceal neoplasm 显示文摘Murphy EM Sexton R Moran BJ 2007Dis Colon Rectum2007,50,1:1
18Epidemiological and clinical aspects of nonsteroidal anti-inflammatory drugs and cancer risks 显示文摘Moran EM 2002J Environ PatholToxicol Oncol2002,21,2:1
19The role of interleukin-17 in immune- mediated inflammatory myopathies and possible therapeutic im- plications 显示文摘Moran EM Mastaglia FL 2014Neuromuscul Disord2014,24,:1
20Computed tomography findings predicting invasiveness of thymoma显示文摘Marom EM Milito MA Moran CA 2011J Thorac Oncol2011,6,7:1
返回顶部 每页显示:
共4页 首页 上一页 第1页 下一页 末页 /4 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费